<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Caspase-9 Archives - Phoenix-Micron</title>
	<atom:link href="https://phoenixmicron.com/tag/caspase-9/feed/" rel="self" type="application/rss+xml" />
	<link>https://phoenixmicron.com/tag/caspase-9/</link>
	<description></description>
	<lastBuildDate>Thu, 02 Apr 2026 17:50:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://phoenixmicron.com/wp-content/uploads/2023/11/Gold-and-White-Real-Estate-Agency-Logo-Template-1-150x150.png</url>
	<title>Caspase-9 Archives - Phoenix-Micron</title>
	<link>https://phoenixmicron.com/tag/caspase-9/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Caspase-9 inhibiting eyedrops rescue physiological and functional retinal vein occlusion damage shown with Phoenix MICRON®, OCT, and focal ERG</title>
		<link>https://phoenixmicron.com/caspase-9-inhibiting-eyedrops-rescue-physiological-and-functional-retinal-vein-occlusion-damage-shown-with-phoenix-micron-oct-and-focal-erg/</link>
		
		<dc:creator><![CDATA[Phoenix-Micron Team]]></dc:creator>
		<pubDate>Tue, 21 Jul 2020 23:55:22 +0000</pubDate>
				<category><![CDATA[fERG]]></category>
		<category><![CDATA[fluorescein angiography]]></category>
		<category><![CDATA[InSight]]></category>
		<category><![CDATA[Micron IV]]></category>
		<category><![CDATA[OCT]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[anti-VEGF]]></category>
		<category><![CDATA[Caspase-9]]></category>
		<category><![CDATA[mice]]></category>
		<category><![CDATA[mouse]]></category>
		<category><![CDATA[Nature Communications]]></category>
		<category><![CDATA[Retina]]></category>
		<category><![CDATA[retinal vein occlusion]]></category>
		<guid isPermaLink="false">https://phoenixmicrdev.wpengine.com/?p=3669</guid>

					<description><![CDATA[<p>In a recent well written, compelling article published in Nature Communications, “Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion,” Avrutsky et al show that caspase-9 inhibition is a promising treatment for retinal vein occlusion. Retinal vein occlusion models hypoxic-ischemic neurovascular damage and is the second leading cause of blindness in working-age adults. [&#8230;]</p>
<p>The post <a href="https://phoenixmicron.com/caspase-9-inhibiting-eyedrops-rescue-physiological-and-functional-retinal-vein-occlusion-damage-shown-with-phoenix-micron-oct-and-focal-erg/">Caspase-9 inhibiting eyedrops rescue physiological and functional retinal vein occlusion damage shown with Phoenix MICRON&lt;span class=&quot;reg-mark half-size&quot;&gt;®&lt;/span&gt;, OCT, and focal ERG</a> appeared first on <a href="https://phoenixmicron.com">Phoenix-Micron</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
